Nutromics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
63
- Latest Deal Type
-
Series B
- (Upcoming)
- Investors
-
16
Nutromics General Information
Description
Developer of medical-grade diagnostics equipment designed to diagnose through their DNA-based sensor platform. The company's technology offers a wearable sensor and software that continuously monitors biomarkers for diet, sleep, stress, and exercise and delivers real-time data and new insights for an effective lifestyle change, enabling patients to take preventative measures to reduce the risk of diabetes.
Contact Information
Website
www.nutromics.comCorporate Office
- 420 Victoria Street
- Brunswick, Victoria 3056
- Australia
Corporate Office
- 420 Victoria Street
- Brunswick, Victoria 3056
- Australia
Nutromics Timeline
Nutromics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Later Stage VC (Series B) | Upcoming | Generating Revenue | ||||
| 15. Later Stage VC | 02-Sep-2025 | Completed | Generating Revenue | |||
| 14. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 13. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 12. Later Stage VC | 28-May-2024 | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | 19-Apr-2024 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 08-Jun-2023 | Cancelled | Generating Revenue | |||
| 9. Later Stage VC | 08-Jun-2023 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 01-Jan-2023 | $18.7M | Completed | Generating Revenue | ||
| 7. Later Stage VC | 08-Sep-2022 | $14M | $18.7M | Completed | Generating Revenue |
Nutromics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A Preference Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Nutromics Comparisons
Industry
Financing
Details
Nutromics Competitors (12)
One of Nutromics’s 12 competitors is NalaGenetics, a Venture Capital-Backed company based in Singapore, Singapore.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NalaGenetics | Venture Capital-Backed | Singapore, Singapore | ||||
| BioFire | Venture Capital-Backed | Salt Lake City, UT | ||||
| Genomind | Venture Capital-Backed | King of Prussia, PA | ||||
| Cepheid | Formerly VC-backed | Sunnyvale, CA | ||||
| DoseMe | Formerly VC-backed | Taringa, Australia |
Nutromics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nutromics Patents
Nutromics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026076489-A1 | Electrochemical temperature measurement using redox-active polymers | Pending | 09-Oct-2024 | ||
| WO-2026055744-A1 | Working electrode for an electrochemical sensor | Pending | 12-Sep-2024 | ||
| WO-2026025148-A1 | Methods for reducing bioburden of a sensor electrode | Pending | 29-Jul-2024 | ||
| WO-2025255618-A1 | Apparatus and methods for assessing drug tissue distribution | Pending | 14-Jun-2024 | ||
| WO-2025213213-A1 | Improved operation of an electrochemical sensor | Pending | 09-Apr-2024 | G01N33/5438 |
Nutromics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nutromics Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| GraceMed | PE-Backed Company | Minority | ||
| Ironman | PE-Backed Company | Minority | ||
| Traverse Ventures | Venture Capital | Minority | ||
| Jumar Bioincubator | Accelerator/Incubator | |||
| CONNECT (San Diego) | Accelerator/Incubator |
Nutromics FAQs
-
When was Nutromics founded?
Nutromics was founded in 2017.
-
Where is Nutromics headquartered?
Nutromics is headquartered in Brunswick, Australia.
-
What is the size of Nutromics?
Nutromics has 63 total employees.
-
What industry is Nutromics in?
Nutromics’s primary industry is Monitoring Equipment.
-
Is Nutromics a private or public company?
Nutromics is a Private company.
-
What is Nutromics’s current revenue?
The current revenue for Nutromics is .
-
How much funding has Nutromics raised over time?
Nutromics has raised $62.5M.
-
Who are Nutromics’s investors?
GraceMed, Ironman, Traverse Ventures, Jumar Bioincubator, and CONNECT (San Diego) are 5 of 16 investors who have invested in Nutromics.
-
Who are Nutromics’s competitors?
NalaGenetics, BioFire, Genomind, Cepheid, and DoseMe are some of the 12 competitors of Nutromics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
